Clara Biotech hits $850K in seed funding roundup, preparing to launch first product

June 15, 2021  |  Startland News Staff

Clara Biotech team

An emerging biotech startup in the region is reporting a busy spring with a significant seed round already raised and key steps under way to launch its product: a solution that removes manufacturing roadblocks for breakthrough drugs.

“We’re in an exciting and growing space and currently have low regulatory hurdles in the research stage,” said Jim West, co-founder of Clara Biotech, a Lawrence-based company already buoyed by its founding team’s expertise in exosome technologies, pharmaceutical development, engineering and building life science companies.

Elevator pitch: ​​Clara Biotech is building an exosome isolation platform that solves a huge roadblock around manufacturing that helps the entire biopharma industry make future breakthrough drugs that may not otherwise get approved. We founded Clara Biotech to help move exosomes from research to patient.

James West, Clara Biotech

Jim West, Clara Biotech

“We’re looking for smart money investors who can help us develop our market position, scale the technology and become the platform that companies can use to get exosome therapies to the patients who need them most,” he continued, detailing Clara Biotech’s momentum in a company snapshot update.

Off the heels of announcing an undisclosed investment by Kansas City-based Fountain Innovation Fund, the startup has raised $850,000 for its seed round, West said, with additional investments from angel investors in Boston, San Francisco, India and Kansas City.

Mei He, Clara Biotech

Dr. Mei He, Clara Biotech

Clara Biotech recently received a tranche of angel tax credits, still available to qualified investors, he added.

The seed round is expected to help the company debut its beta ExoRelease exosome isolation kit, as well as continue to scale, West said.

Click here to read Clara Biotech’s full snapshot update.

“We are generating revenue and launching our first product,” he said. “At a recent conference for exosome therapeutics, sample preparation quality was the major limiting factor in manufacturing and receiving FDA approval. Our groundbreaking solution resulted in a 70 percent lead conversion rate of all companies attending (which includes investment groups and competitors). We’re currently working with and growing a number of paying early customers including some major pharmaceutical players.”

Founded in 2018 at the Bioscience and Technology Business Center in Lawrence, Clara Biotech’s therapeutic applications range from personalized medicine, targeted drug delivery, immunotherapy, and orphan and rare diseases. It’s solutions are focused on early cancer detection, Alzheimer’s disease, and virus detection.

Click here to learn more about Clara Biotech and how its technology works.

This story is possible thanks to support from the Ewing Marion Kauffman Foundation, a private, nonpartisan foundation that seeks to build inclusive prosperity through a prepared workforce and entrepreneur-focused economic development. The Foundation works to change conditions, address root causes, and break down systemic barriers so that all people – regardless of race, gender, or geography – have the opportunity to achieve economic stability, mobility, and prosperity. 

For more information, visit www.kauffman.org and connect with us at www.twitter.com/kauffmanfdn and www.facebook.com/kauffmanfdn.

startland-tip-jar

TIP JAR

Did you enjoy this post? Show your support by becoming a member or buying us a coffee.

Tagged , , ,
Featured Business
    Featured Founder

      2021 Startups to Watch

        stats here

        Related Posts on Startland News

        KC seamstress reaffirms gender identities, provides confidence through compression garments  

        By Tommy Felts | September 30, 2022

        Every individual deserves to express how they feel on the inside through their outer appearance, Laura Treas shared; and clothing has the power to make that transition.  “Fashion can appear to be so shallow, but we know that isn’t the case. Our undergarments give someone the look and silhouette on the outside that they feel…

        These brothers brought artisan Mexican designs to the streets of KC; now Pancho’s Blanket is opening a Crossroads shop

        By Tommy Felts | September 30, 2022

        A handmade Mexican garment company led by brothers Jonathan and Joseph Garvey is quickly making the leap from First Friday pop up to Crossroads storefront — announcing the debut of a permanent home for the shop next week. Pancho’s Blanket — which partners with artisans in Tlaxcala, Mexico, to design and make wool jackets, blankets,…

        KC inventor’s untimely death leaves legacy of fearlessness, unfinished vision

        By Tommy Felts | September 29, 2022

        Paul Francis pioneered fitness tech for NASA, commercialized it with Bowflex, then raised $4 million on Kickstarter: How the OYO founder’s unexpected death this month cut his storied entrepreneurial journey short — but left a lasting impression on the people who worked alongside him. Former colleagues are remembering the late Paul Francis as a uniquely…

        Pitches and peaches: Hy-Vee awards $30K piece of the $50K prize pie to family-run cobbler company

        By Tommy Felts | September 29, 2022

        Denisha Jones sweetened Hy-Vee’s OpportUNITY Inclusive Business Summit and pitch competition this week with her ready-to-bake cobblers. Her pitch (and peaches) secured the $30,000 grand prize.  “Every time Thanksgiving comes around, I always crave my grandmother’s cobbler. During the pandemic, I was unsuccessful in finding a cobbler as good as my grandmother’s, so I went…